0001140361-18-022841.txt : 20180510 0001140361-18-022841.hdr.sgml : 20180510 20180510175656 ACCESSION NUMBER: 0001140361-18-022841 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180508 FILED AS OF DATE: 20180510 DATE AS OF CHANGE: 20180510 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LINDAHL RICHARD S CENTRAL INDEX KEY: 0001196632 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33137 FILM NUMBER: 18824321 MAIL ADDRESS: STREET 1: NEXTEL STREET 2: 2001 EDMUND HALLEY DR CITY: RESTON STATE: VA ZIP: 20191 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Emergent BioSolutions Inc. CENTRAL INDEX KEY: 0001367644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 141902018 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 BUSINESS PHONE: 240-631-3200 MAIL ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 4 1 doc1.xml FORM 4 X0306 4 2018-05-08 0 0001367644 Emergent BioSolutions Inc. EBS 0001196632 LINDAHL RICHARD S 400 PROFESSIONAL DRIVE, SUITE 400 GAITHERSBURG MD 20879 0 1 0 0 EVP, Chief Financial Officer Common Stock 2018-05-08 4 A 0 4992 0.00 A 4992 D Common Stock 2018-05-08 4 A 0 1551 0.00 A 6543 D Common Stock 2018-05-08 4 A 0 4991 0.00 A 11534 D Employee Stock Option (Right to Buy) 48.33 2018-05-08 4 A 0 19963 48.33 A 2025-05-07 Common Stock 19963 19963 D Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended. These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement. Consists of performance stock units granted under the Amended and Restated 2006 Emergent BioSolutions Inc. Stock Incentive Plan, as amended. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to net income as a percentage of total revenue for the 2020 fiscal year, each as determined in accordance with GAAP, as certified by the Compensation Committee following the performance period. Vests in three equal installments on May 7, 2019, May 7, 2020 and May 7, 2021. /s/ S. Scott Lieberman, Attorney-in-fact 2018-05-10